Previous 10 | Next 10 |
2023-07-09 12:00:00 ET Despite a disappointing start to 2023, the healthcare sector has several promising industries waiting to outperform this year, Goldman Sachs said in a recent report after the bank concluded its annual healthcare conference in Dana Point, California, last month. Th...
2023-06-12 23:39:04 ET Summary Edwards Lifesciences is still reporting solid top-line growth in Q1/23 but the bottom line declined and fiscal 2022 also saw low growth rates. Aside from actual growth rates in the last few quarters, Edwards Lifesciences is a high-quality business wi...
2023-06-12 17:55:23 ET Summary Edwards Lifesciences is now down over 35% from its all-time high. The company should continue to benefit from the market expansion of TAVR amid the growing aging population and increasing life expectancy. The latest earnings were mixed as top-lin...
2023-06-12 13:42:19 ET Summary Medical device stocks, including Edwards Lifesciences, have struggled in recent years, with EW's stock wavering amid uncertainty around its Transcatheter Aortic Valve Replacement procedure. Despite solid Q1 results and increased full-year sales guida...
2023-06-10 18:55:00 ET The Citi quantitative team is still confident about its Oversold Strategy, despite a second stumble in returns this year. "Our systematic Oversold Strategy posted its second loss (-4%) this year in May, as the equity market is following more closely on the credit ...
2023-05-24 02:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
DATA FROM BENCHMARK REGISTRY DEMONSTRATE IMPROVED TAVR EFFICIENCY WITH PRESERVED PATIENT SAFETY PR Newswire PARIS , May 17, 2023 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) announced today that new data from the Benchmark Registry in Europe demonstrated t...
EDWARDS' AORTIC VALVE WITH RESILIA TISSUE SHOWS FAVORABLE DURABILITY, SAFETY AND EFFICACY OUTCOMES IN SEVEN YEAR DATA PR Newswire LOS ANGELES , May 7, 2023 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced new data from the COMMENCE aortic trial, de...
2023-05-04 18:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-05-02 17:00:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. During the first quarter, Baron Opportunity Fund® climbed 17.96% (Institutional S...
News, Short Squeeze, Breakout and More Instantly...
Edwards Lifesciences Corporation Company Name:
EW Stock Symbol:
NYSE Market:
Edwards Lifesciences Corporation Website:
Vancouver, British Columbia--(Newsfile Corp. - July 30, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") is pleased to provide this update in regard to the status of the proposed return of capital announced on June 19, 2024 . The Company has prepared and mailed its ...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 1.7% to $112.28 on volume of 455,296,152 shares Ford Motor Company (F) fell 18.4% to $11.16 on volume of 256,384,806 shares PROSHARES TRUST (SQQQ) rose 3.4% to $9.37 on volume of 246,885,889 shares Sel...
2024-07-25 16:00:08 ET Pito Chickering from Deutsche Bank issued a price target of $85.00 for EW on 2024-07-25 13:36:00. The adjusted price target was set to $85.00. At the time of the announcement, EW was trading at $60.58. The overall price target consensus is at $109....